Medicreate AB
ActiveKey figures
Key figures
2025Summary: Medicreate AB
What kind of company is it?
Medicreate AB (org. no. 556796-5404) is a limited company (AB). The company was registered in 2009 and has existed for 16 years. Registered seat: Sjömarken. Industry according to Statistics Sweden: specialist medical practice activities, at hospitals (SNI 86221).
How is the company doing financially?
Net sales in financial year 2025 were 240 000 kr, down 13,7 % on the previous year (278 000 kr). From 2023 to 2025, net sales declined by an average of 58,7 % per year. Net profit for 2025 was 3 289 kr (1,4 % of net sales). The company was profitable in all 3 reported financial years. Employees in financial year 2025: 1. Net sales per employee were 240 000 kr. At the end of financial year 2025, total assets were 6 445 673 kr and equity 6 119 344 kr (equity ratio 94,9 %). The annual report for 2025 proposes a dividend of 322 000 kr.
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Dividend
from the annual reportProposed dividend 322 000 kr.
Summary of annual reports2023–2025
| 2023 | 2024 | 2025 | |
|---|---|---|---|
| Sales revenue | 1 404 000 | 278 000 | 240 000 |
| Profit for the reporting year | 968 069 | 2 797 996 | 3 289 |
| Retained earnings of previous periods | — | — | — |
| Total assets | 4 239 594 | 6 635 573 | 6 445 673 |
| Total liabilities | 508 534 | 310 517 | 326 329 |
| Total equity | 3 731 060 | 6 325 056 | 6 119 344 |
| Employees | 1 | 1 | 1 |
| Proposed dividend | — | 209 000 | 322 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.